Project management

Burrell Communications Group announces agency restructuring

Retrieved on: 
Montag, Mai 6, 2024

CHICAGO, May 6, 2024 /PRNewswire/ -- Burrell Communications Group, one of the world's most highly regarded Black-owned advertising agencies, has announced the appointment and promotion of several senior-level executives to complete its long anticipated restructuring, and its growing leadership roster. The group will work together to seamlessly create centers of brilliance around core disciplines and improve agency operations, while strategically guiding Burrell's evolution as it moves confidently through its first year with CEO Tara DeVeaux at the helm.

Key Points: 
  • Legacy agency hires and promotes an all-star group of leaders to shepherd the new direction of Burrell, and to power its future
    CHICAGO, May 6, 2024 /PRNewswire/ -- Burrell Communications Group, one of the world's most highly regarded Black-owned advertising agencies, has announced the appointment and promotion of several senior-level executives to complete its long anticipated restructuring, and its growing leadership roster.
  • The group will work together to seamlessly create centers of brilliance around core disciplines and improve agency operations, while strategically guiding Burrell's evolution as it moves confidently through its first year with CEO Tara DeVeaux at the helm.
  • "I am truly excited and inspired by these individuals and their strong track-records of career success and accomplishment," states DeVeaux.
  • Our entire staff, along with our clients, are thrilled by the selection of this dream team."

Managing Biomarker/Companion Diagnostic (CDx) Programs with Pharma: A Diagnostic Company's Perspective, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Montag, Mai 6, 2024

TORONTO, May 6, 2024 /PRNewswire-PRWeb/ -- The partnership between a diagnostic provider and a pharmaceutical/biotechnology company is crucial when developing a companion diagnostic (CDx). It is important to ensure that the strategic approach for the therapy and diagnostic is aligned to achieve the same clinical, regulatory and commercial goals, as well as aligned with the program risk profile.

Key Points: 
  • TORONTO, May 6, 2024 /PRNewswire-PRWeb/ -- The partnership between a diagnostic provider and a pharmaceutical/biotechnology company is crucial when developing a companion diagnostic (CDx).
  • In fact, the clinical trial design can affect diagnostic development; therefore, there are many challenges associated with a diagnostic–pharma partnership.
  • They will also explore some of the realities of managing CDx development programs with pharma and biotech partners from a diagnostic providers' perspective.
  • Register for this webinar today to gain insights into the realities of managing CDx development programs with pharma and biotech partners from a diagnostic providers' perspective.

CENTURY LITHIUM ANNOUNCES POSITIVE FEASIBILITY STUDY FOR THE CLAYTON VALLEY LITHIUM PROJECT, NEVADA

Retrieved on: 
Montag, April 29, 2024

The QP for the estimate is Ms. Terre Lane, MMSA, an employee of GRE and independent of Century.

Key Points: 
  • The QP for the estimate is Ms. Terre Lane, MMSA, an employee of GRE and independent of Century.
  • Metallurgical testing through 2020 focused on using sulfuric acid (H2SO4) to extract lithium from the clay.
  • A lithium recovery of 78% is used in the Feasibility Study, based on the data collected in over two years of operations at the Pilot Pant.
  • Contributors to the estimates are GRE (mining), Wood (process plant and infrastructure), ThyssenKrupp Nucera (chlor-alkali plant) and Century Lithium (property information and owners' costs).

Baker Hughes Awarded Significant Gas Technology Scope for Phase 3 of Saudi Arabia’s Master Gas System

Retrieved on: 
Dienstag, April 23, 2024

Award builds on Master Gas System Phase 1 & 2 agreement, which saw Baker Hughes deliver 18 centrifugal compressors driven by aeroderivative gas turbines

Key Points: 
  • Award builds on Master Gas System Phase 1 & 2 agreement, which saw Baker Hughes deliver 18 centrifugal compressors driven by aeroderivative gas turbines
    New pipeline aims to increase gas distribution across Saudi Arabia, supporting the Kingdom’s ambition to reduce carbon emissions
    HOUSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR), an energy technology company, announced Tuesday that it has received an order by Worley, for and on behalf of Aramco, to supply gas technology equipment for the third phase of Saudi Arabia’s Master Gas System project.
  • Baker Hughes will supply 17 pipeline centrifugal compressors driven by state-of-the-art aeroderivative gas turbines for Aramco’s project.
  • The order follows the delivery of 18 of Baker Hughes centrifugal compressors driven by aeroderivative gas turbines for Phase 1 and 2 of the Master Gas System projects executed by Baker Hughes.
  • “Baker Hughes solutions are advancing the efficient use of natural gas, and we are proud to be delivering a reliable system to transport and distribute gas across Saudi Arabia.”
    Baker Hughes is also investing in expanding its manufacturing site in Modon, Saudi Arabia.

ADS-TEC Energy Appoints Automotive and Mobility Expert, Alwin Epple, as Newest Board Member

Retrieved on: 
Montag, April 29, 2024

ADS-TEC Energy plc (“ADS-TEC Energy”, “Company”, “we”, “our” or “us”) (NASDAQ: ADSE), a global leader in battery-buffered, ultra-fast charging technology, is pleased to announce the appointment of Alwin Epple to its Board of Directors.

Key Points: 
  • ADS-TEC Energy plc (“ADS-TEC Energy”, “Company”, “we”, “our” or “us”) (NASDAQ: ADSE), a global leader in battery-buffered, ultra-fast charging technology, is pleased to announce the appointment of Alwin Epple to its Board of Directors.
  • View the full release here: https://www.businesswire.com/news/home/20240429129397/en/
    New Board Member for ADS-TEC Energy, Alwin Epple (Photo: Business Wire)
    Mr. Epple has held prominent positions at Daimler AG and Mercedes Benz Group for the past 20 years.
  • “To join the board of ADS-TEC Energy PLC is an honor and very exciting,” said Alwin Epple.
  • “The opportunity to contribute to the transformation of automotive mobility through ultrafast charging and battery storage solutions is motivating.”

ADS-TEC Energy Appoints Automotive and Mobility Expert, Alwin Epple as Newest Board Member

Retrieved on: 
Montag, April 29, 2024

ADS-TEC Energy plc (“ADS-TEC Energy”, “Company”, “we”, “our” or “us”) (NASDAQ: ADSE), a global leader in battery-buffered, ultra-fast charging technology, is pleased to announce the appointment of Alwin Epple to its Board of Directors.

Key Points: 
  • ADS-TEC Energy plc (“ADS-TEC Energy”, “Company”, “we”, “our” or “us”) (NASDAQ: ADSE), a global leader in battery-buffered, ultra-fast charging technology, is pleased to announce the appointment of Alwin Epple to its Board of Directors.
  • With an illustrious career in the automotive industry spanning over three decades, Mr. Epple brings a wealth of experience and expertise to the company’s leadership team.
  • “To join the board of ADS-TEC Energy PLC is an honor and very exciting,” said Alwin Epple.
  • “The opportunity to contribute to the transformation of automotive mobility through ultrafast charging and battery storage solutions is motivating.”

Project Management Profession Contributes £186bn to UK Economy After £30bn Five-year Growth – APM Golden Thread Report 2024

Retrieved on: 
Donnerstag, April 25, 2024

A new report by the Association for Project Management (APM), the chartered membership organisation for the project profession, has found that project management in the UK contributes £186.8 billion of annual gross value added (GVA) to the UK economy – a growth of over £30bn in the last five years.

Key Points: 
  • A new report by the Association for Project Management (APM), the chartered membership organisation for the project profession, has found that project management in the UK contributes £186.8 billion of annual gross value added (GVA) to the UK economy – a growth of over £30bn in the last five years.
  • The Golden Thread Report 2024 , commissioned by APM and conducted by PwC Research, shows that key drivers behind the growth include professional and business services – the largest contributor to project management GVA at £47.9bn, a rise of 22% from 2019.
  • “The Golden Thread 2024 deepens the view that our profession is the most vital ‘golden thread’ running through all sectors of the economy – driving quality, efficiency and strategic change.
  • Now they are thinking more about driving step-change, improvements and ultimately transformation.”
    To download the Golden Thread 2024 Report along with supporting case studies, visit https://www.apm.org.uk/resources/research/the-golden-thread/
    Further key findings from the Golden Thread report:

Swisslog Healthcare Welcomes Brian Roberts as SVP of Medication Management, North America

Retrieved on: 
Montag, April 22, 2024

Swisslog Healthcare , a global industry leader in pharmacy and transport automation solutions, announced the appointment of Brian Roberts as the Senior Vice President of Sales and Services in North America for the Medication Management business unit.

Key Points: 
  • Swisslog Healthcare , a global industry leader in pharmacy and transport automation solutions, announced the appointment of Brian Roberts as the Senior Vice President of Sales and Services in North America for the Medication Management business unit.
  • Roberts will report to Jan Zuurbier , the General Manager for the Medication Management business unit of Swisslog Healthcare.
  • “Brian will have a dedicated focus on the North American healthcare automation market, build a further presence for Swisslog Healthcare in the broader hospital industry, and provide attentive leadership for the functional leaders who are driving our day-to-day customer interactions,” said Jan Zuurbier, General Manager for the Medication Management business unit of Swisslog Healthcare.
  • With Roberts leading the Sales and Services in North America for the Medication Management business unit, Swisslog Healthcare remains dedicated to its mission to provide unparalleled services and innovative solutions to its customers in North America and beyond.

XYZ Reality Welcomes Data Center Industry Leaders Christian Belady and Brian Mattson as Strategic Advisors

Retrieved on: 
Dienstag, April 16, 2024

XYZ Reality , the leading engineering grade augmented reality (AR) platform for data center and mission critical construction, is proud to announce the appointment of data center industry veterans Christian Belady and Brian Mattson as Strategic Advisors.

Key Points: 
  • XYZ Reality , the leading engineering grade augmented reality (AR) platform for data center and mission critical construction, is proud to announce the appointment of data center industry veterans Christian Belady and Brian Mattson as Strategic Advisors.
  • With their extensive experience and innovative vision, they will help guide XYZ Reality in enhancing its data center construction solution and product roadmap.
  • Formerly Vice President and Distinguished Engineer at Microsoft, Belady developed one of the largest data center footprints in the world.
  • "We are delighted to welcome Christian Belady and Brian Mattson to XYZ Reality as Strategic Advisors," said David Mitchell, Founder & CEO of XYZ Reality.

Key Considerations for Cell Therapy Trials Beyond Oncology, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Dienstag, April 23, 2024

TORONTO, April 23, 2024 /PRNewswire-PRWeb/ -- Cell therapy represents a groundbreaking frontier in medical treatment, presenting unprecedented potential for addressing a diverse array of medical conditions where traditional therapies have failed. However, the successful execution of cell therapy clinical trials demands meticulous attention to detail from clinical sites to safeguard patient welfare, uphold regulatory standards and achieve trial objectives.

Key Points: 
  • In this free webinar, learn the essential infrastructure requirements necessary for clinical sites to effectively manage cell therapy products in non-oncology clinical trials.
  • Attendees will learn the key considerations in patient selection criteria for non-oncology cell therapy trials, including factors influencing eligibility.
  • The featured speakers will share best practices and safety protocols for ensuring patient safety throughout the duration of non-oncology cell therapy clinical trials, including proactive adverse event monitoring and management strategies.
  • Register for this webinar today to learn key considerations of cell therapy trials, from clinical site readiness to ensuring patient safety, all while meeting trial goals.